[BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16]
- PMID: 7000202
[BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16]
Abstract
The effect of BCG on the growth of melanoma B16 and production of the macrophage migration inhibitory factor (MMIF) by spleen lymphocytes as well as on phytohemagglutinin and tuberculin was studied in C57BL/6 mice. It was also studied how these parameters changed under the effect of transplanting splenocytes from syngeneic donors. Subcutaneous or intraperitoneal injection of BCG in a dose of 1 mg stimulated melanoma growth. Acceleration of the tumor growth entailed a more pronounced decrease in MMIF production. The inhibition of melanoma growth was noted after transplantation of splenocytes from syngeneic donors on the 11th day following inoculation of the tumor wherein MMIF production was normal. Transplantation of splenocytes from mice immunized with BCG resulted in an abrupt stimulation of melanoma growth and complete reversal of MMIF production by lymphocytes. The data obtained suggest the accumulation of suppressor cells by the spleen of mice treated with high doses of BCG, leading to the acceleration of melanoma B16 growth.
Similar articles
-
Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection.Immunology. 1982 Apr;45(4):655-61. Immunology. 1982. PMID: 6175566 Free PMC article.
-
Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.Cancer Gene Ther. 2000 Oct;7(10):1365-74. doi: 10.1038/sj.cgt.7700248. Cancer Gene Ther. 2000. PMID: 11059695
-
Effect of lymphokine-containing sera on adenocarcinoma BW10232 and melanoma B16 in C57BL/6 mice.J Natl Cancer Inst. 1980 Apr;64(4):901-3. J Natl Cancer Inst. 1980. PMID: 6154164
-
Facilitation and inhibition of b16 melanoma by BCG in vivo and by lymphoid cells from bcg-treated mice in vitro.Int J Cancer. 1974 Jul 15;14(1):137-43. doi: 10.1002/ijc.2910140117. Int J Cancer. 1974. PMID: 4617706 Review. No abstract available.
-
[Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].Kekkaku. 1980 Aug;55(8):359-63. Kekkaku. 1980. PMID: 6999203 Review. Japanese. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical